MSD and Daiichi Sankyo have announced first subject dosing in the IDeate-Prostate01 Phase III trial of ifinatamab deruxtecan ...

Dr. Joshua K. Sabari and Dr. Daniel V. Araujo provide expert insights into genitourinary cancer updates from ASCO 2025.

George Evans had the opportunity of a lifetime as he stepped up to the mound to throw the first pitch at the Athletics game against the Houston Astros ...

Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, announced ...

Seven-year follow-up data on over 1400 patients show radium-223's long-term safety, with a low 2% secondary malignancy rate, reflecting real-world use.

Engaging in leisure-time moderate- to vigorous-intensity physical activity (MVPA) is associated with better overall survival for participants with a history of various cancers.

AMPLITUDE is the “first trial to show efficacy for the combination of inhibition of PARP and the androgen receptor pathway in metastatic, castration-sensitive prostate cancer with alteration of genes ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Studies presented at the ASCO Annual Meeting 2025 highlighted immunotherapies that may provide new standards of care for certain cancers as well as immunotherapies that are breaking new ground by ...

The University of Liverpool is leading a major €8.6m (£7m) EU-funded research project to tackle a growing medical challenge ...

As a correspondent for the Atlantic, Vanity Fair and the New York Times, he wrote vivid accounts of aviation disasters, shipwrecks and the Iraq War.

Rhod Gilbert and the Giant Grapefruit at Eventim Apollo: 'rage, heart and lashings of dark humour' - 5/5 The Welsh comedian’s ...